WEKO3
アイテム
{"_buckets": {"deposit": "fd8b1b53-6d60-4e08-be08-a2511399879d"}, "_deposit": {"created_by": 1, "id": "48146", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "48146"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00048146", "sets": ["1"]}, "author_link": ["483493", "483491", "483488", "483496", "483489", "483494", "483495", "483492", "483490", "483497"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "24", "bibliographicPageStart": "16", "bibliographicVolumeNumber": "16", "bibliographic_titles": [{"bibliographic_title": "Molecular cancer therapeutics"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Hsp90 inhibitors have been investigated as cancer therapeutics in monotherapy and to augment radiotherapy; however, serious adverse effects of early-generation Hsp90 inhibitors limited their development. TAS-116 is a novel Hsp90 inhibitor with lower adverse effects than other Hsp90 inhibitors, and here, we investigated the radiosensitizing effects of TAS-116 in low linear energy transfer (LET) X-ray and high LET carbon ion-irradiated human cancer cells and mouse tumor xenografts. TAS-116 decreased cell survival of both X-ray and carbon ion-irradiated human cancer cell lines (HeLa and H1299 cells), and similar to other Hsp90 inhibitors, it did not affect radiosensitivity of noncancerous human fibroblasts. TAS-116 increased the number of radiation-induced γ-H2AX foci and delayed the repair of DNA double-strand breaks (DSB). TAS-116 reduced the expression of proteins that mediate repair of DSBs by homologous recombination (RAD51) and nonhomologous end joining (Ku, DNA-PKcs), and suppressed formation of RAD51 foci and phosphorylation/activation of DNA-PKcs. TAS-116 also decreased expression of the cdc25 cell-cycle progression marker, markedly increasing G2-M arrest. Combined treatment of mouse tumor xenografts with carbon ions and TAS-116 showed promising delay in tumor growth compared with either individual treatment. These results demonstrate that TAS-116 radiosensitizes human cancer cells to both X-rays and carbon ions by inhibiting the two major DSB repair pathways, and these effects were accompanied by marked cell-cycle arrest. The promising results of combination TAS-116 + carbon ion radiotherapy of tumor xenografts justify further exploration of TAS-116 as an adjunct to radiotherapy using low or high LET radiation. Mol Cancer Ther; 16(1); 16-24. ©2016 AACR.", "subitem_description_type": "Abstract"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "28062703", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1158/1535-7163.MCT-16-0573", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1535-7163", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Lee, Younghyun"}], "nameIdentifiers": [{"nameIdentifier": "483488", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sunada, Shigeaki"}], "nameIdentifiers": [{"nameIdentifier": "483489", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirakawa, Hirokazu"}], "nameIdentifiers": [{"nameIdentifier": "483490", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujimori, Akira"}], "nameIdentifiers": [{"nameIdentifier": "483491", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "A, Nickoloff Jac"}], "nameIdentifiers": [{"nameIdentifier": "483492", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okayasu, Ryuichi"}], "nameIdentifiers": [{"nameIdentifier": "483493", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "砂田 成章", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "483494", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "平川 博一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "483495", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤森 亮", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "483496", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡安 隆一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "483497", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/48146", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-07-24"}, "publish_date": "2017-07-24", "publish_status": "0", "recid": "48146", "relation": {}, "relation_version_is_last": true, "title": ["TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation."], "weko_shared_id": -1}
TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
https://repo.qst.go.jp/records/48146
https://repo.qst.go.jp/records/48146c717b8f4-2866-44e8-868a-09f8bb8c999a
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-07-24 | |||||
タイトル | ||||||
タイトル | TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Lee, Younghyun
× Lee, Younghyun× Sunada, Shigeaki× Hirakawa, Hirokazu× Fujimori, Akira× A, Nickoloff Jac× Okayasu, Ryuichi× 砂田 成章× 平川 博一× 藤森 亮× 岡安 隆一 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Hsp90 inhibitors have been investigated as cancer therapeutics in monotherapy and to augment radiotherapy; however, serious adverse effects of early-generation Hsp90 inhibitors limited their development. TAS-116 is a novel Hsp90 inhibitor with lower adverse effects than other Hsp90 inhibitors, and here, we investigated the radiosensitizing effects of TAS-116 in low linear energy transfer (LET) X-ray and high LET carbon ion-irradiated human cancer cells and mouse tumor xenografts. TAS-116 decreased cell survival of both X-ray and carbon ion-irradiated human cancer cell lines (HeLa and H1299 cells), and similar to other Hsp90 inhibitors, it did not affect radiosensitivity of noncancerous human fibroblasts. TAS-116 increased the number of radiation-induced γ-H2AX foci and delayed the repair of DNA double-strand breaks (DSB). TAS-116 reduced the expression of proteins that mediate repair of DSBs by homologous recombination (RAD51) and nonhomologous end joining (Ku, DNA-PKcs), and suppressed formation of RAD51 foci and phosphorylation/activation of DNA-PKcs. TAS-116 also decreased expression of the cdc25 cell-cycle progression marker, markedly increasing G2-M arrest. Combined treatment of mouse tumor xenografts with carbon ions and TAS-116 showed promising delay in tumor growth compared with either individual treatment. These results demonstrate that TAS-116 radiosensitizes human cancer cells to both X-rays and carbon ions by inhibiting the two major DSB repair pathways, and these effects were accompanied by marked cell-cycle arrest. The promising results of combination TAS-116 + carbon ion radiotherapy of tumor xenografts justify further exploration of TAS-116 as an adjunct to radiotherapy using low or high LET radiation. Mol Cancer Ther; 16(1); 16-24. ©2016 AACR. | |||||
書誌情報 |
Molecular cancer therapeutics 巻 16, 号 1, p. 16-24, 発行日 2017-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1535-7163 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 28062703 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1158/1535-7163.MCT-16-0573 |